30. 7P2K Solution NMR Structure of Arginine to Cysteine mutant of Arkadia RING domain (2021)
30. 7P2K Solution NMR Structure of Arginine to Cysteine mutant of Arkadia RING domain (2021)
Deposited Structural and NMR data – Atomic Coordinates of NMR models & Chemical Shifts
PDB – Protein Data Bank
29. 7P2O NMR solution structure of SUD-C domain of SARS-CoV-2 (2021)
29. 7P2O NMR solution structure of SUD-C domain of SARS-CoV-2 (2021)
28. 7P2K Solution NMR Structure of Arginine to Cysteine mutant of Arkadia RING domain (2021)
28. 7P2K Solution NMR Structure of Arginine to Cysteine mutant of Arkadia RING domain (2021)
27. 7P27 NMR solution structure of from Chikungunya virus macro domain (2021)
27. 7P27 NMR solution structure of from Chikungunya virus macro domain (2021)
26. 6XXU Solution NMR structure of the native form of UbcH7 (UBE2L3) (2019)
26. 6XXU Solution NMR structure of the native form of UbcH7 (UBE2L3) (2019).
25. 5MQX NMR solution structure of macro domain from Venezuelan equine encephalitis virus (VEEV) in complex with ADP-ribose, 21 models (2016)
25. 5MQX NMR solution structure of macro domain from Venezuelan equine encephalitis virus (VEEV) in complex with ADP-ribose, 21 models (2016).
24. 5LG7 Solution NMR structure of Tryptophan to Arginine mutant of Arkadia RING domain, 31 models (2016)
24. 5LG7 Solution NMR structure of Tryptophan to Arginine mutant of Arkadia RING domain, 31 models (2016).
23. 5LG0 Solution NMR structure of Tryptophan to Alanine mutant of Arkadia RING domain, 31 models (2016)
23. 5LG0 Solution NMR structure of Tryptophan to Alanine mutant of Arkadia RING domain, 31 models (2016).
22. 5ISN NMR solution structure of macro domain from Venezuelan equine encephalitis virus, 21 models (2016)
22. 5ISN NMR solution structure of macro domain from Venezuelan equine encephalitis virus, 21 models (2016).
21. 5IQ5 NMR solution structure of Mayaro virus macro domain, 21 models (2016)
21. 5IQ5 NMR solution structure of Mayaro virus macro domain, 21 models (2016).
20. 2M5W NMR Solution structure of the La motif of Dictyostelium discoideum La protein, 31 models (2013)
20. 2M5W NMR Solution structure of the La motif of Dictyostelium discoideum La protein, 31 models (2013).
19. 2L0R NMR structure of the C-terminal Catalytic core domain of Anthrax Lethal Factor, 31 models (2010)
19. 2L0R NMR structure of the C-terminal Catalytic core domain of Anthrax Lethal Factor, 31 models (2010).
18. 2ΚΙΖ Solution structure of Arkadia RING-H2 finger domain, NMR 31 Structures (2009)
18. 2ΚΙΖ Solution structure of Arkadia RING-H2 finger domain, NMR 31 Structures (2009).
17. 2K6V Solution structures of apo Sco1 protein from Thermus Thermophilus, NMR 31 Structures (2008)
17. 2K6V Solution structures of apo Sco1 protein from Thermus Thermophilus, NMR 31 Structures (2008).
16. 2K6Z Solution structures of copper loaded form PCuA (trans conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008).
16. 2K6Z Solution structures of copper loaded form PCuA (trans conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008).
15. 2K6Y Solution structures of apo form PCuA (cis conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008)
15. 2K6Y Solution structures of apo form PCuA (cis conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008).
14. 2K70 Solution structures of copper loaded form PCuA (cis conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008).
14. 2K70 Solution structures of copper loaded form PCuA (cis conformation of the peptide bond involving the nitrogen of P14), NMR 31 Structures (2008).
13. 2K6W Solution structures of apo PCuA (trans conformation of the peptide bond involving the nitrogen of P14) (2008)
13. 2K6W Solution structures of apo PCuA (trans conformation of the peptide bond involving the nitrogen of P14) (2008).
12. 2GCF Solution structure of the N-terminal domain of the copper(I) ATPase PacS in its apo form, NMR 21 Structures (2006)
12. 2GCF Solution structure of the N-terminal domain of the copper(I) ATPase PacS in its apo form, NMR 21 Structures (2006).
11. 1YY2 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006)
11. 1YY2 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006).
10. 1YY1 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006)
10. 1YY1 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006).
9. 1YL9 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005)
9. 1YL9 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005).
8. 1YL8 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005)
8. 1YL8 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005).
1N9V Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-II), NMR 21 structures (2003)
7. 1N9V Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-II), NMR 21 structures (2003).
6. 1N9U Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-I), NMR 21 structures (2003)
6. 1N9U Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-I), NMR 21 structures (2003).
5. 1MNY Dimethyl propionate ester heme-containing cytochrome b5 (2002)
5. 1MNY Dimethyl propionate ester heme-containing cytochrome b5 (2002).
4. 1GOE Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR 40 models (2001)
4. 1GOE Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR 40 models (2001).
3. 1GO9 Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR Minimized Average Structure (2001)
3. 1GO9 Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR Minimized Average Structure (2001).
2. 2GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, 40 structures (1998)
2. 2GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, 40 structures (1998).
1. 1GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, Minimized Average Structure (1998)
1. 1GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, Minimized Average Structure (1998).